Siglec-9 acts as an immune-checkpoint molecule on macrophages in glioblastoma, restricting T-cell priming and immunotherapy responseYan Mei, Guangshuai Jia, Hui Yuan et al.|Nature Cancer|2023Cited by 219
Sirpα on tumor-associated myeloid cells restrains antitumor immunity in colorectal cancer independent of its interaction with CD47Chunliu Huang, Wenfei Jin, Ni Hong et al.|Nature Cancer|2024Cited by 94
SIRPα: A key player in innate immunityYongyi Feng, Jun Chen, Chunliu Huang et al.|European Journal of Immunology|2023Cited by 23
AMPK-dependent Parkin activation suppresses macrophage antigen presentation to promote tumor progressionXinyu Wang, Jun Chen, Chunliu Huang et al.|Science Advances|2025Cited by 12
Author response for "SIRPa: A key player in innate immunity"Yongyi Feng, Jun Chen, Chunliu Huang et al.|Unknown|2023Cited by 0